Treatments for severe pulmonary hypertension

被引：19

作者：

Higenbottam, T ^{[1
]}

Stenmark, K

Simonneau, G

机构：

[1] Univ Sheffield, Sch Med, Div Clin Sci, Sheffield S10 2RX, S Yorkshire, England

[2] Univ Colorado, Hlth Sci Ctr, Dept Crit Care Med & Dev Biol, Denver, CO USA

[3] Univ Paris 11, Hop Antoine Beclere, Serv Pneumol, Clamart, France

来源：

LANCET | 1999年 / 353卷 / 9150期

关键词：

D O I：

10.1016/S0140-6736(98)00330-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：338 / 340

页数：3

共 19 条

[1] Appetite-suppressant drugs and the risk of primary pulmonary hypertension [J].

Abenhaim, L ;

Moride, Y ;

Brenot, F ;

Rich, S ;

Benichou, J ;

Kurz, X ;

Higenbottam, T ;

Oakley, C ;

Wouters, E ;

Aubier, M ;

Simonneau, G ;

Begaud, B .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (09) :609-616

[2] A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension [J].

Barst, RJ ;

Rubin, LJ ;

Long, WA ;

McGoon, MD ;

Rich, S ;

Badesch, DB ;

Groves, BM ;

Tapson, VF ;

Bourge, RC ;

Brundage, BH ;

Koerner, SK ;

Langleben, D ;

Keller, CA ;

Murali, S ;

Uretsky, BF ;

Clayton, LM ;

Jobsis, MM ;

Blackburn, SD ;

Shortino, D ;

Crow, JW .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :296-301

[3]

BOTNEY MD, 1992, AM J PATHOL, V140, P357

[4] AN IMBALANCE BETWEEN THE EXCRETION OF THROMBOXANE AND PROSTACYCLIN METABOLITES IN PULMONARY-HYPERTENSION [J].

CHRISTMAN, BW ;

MCPHERSON, CD ;

NEWMAN, JH ;

KING, GA ;

BERNARD, GR ;

GROVES, BM ;

LOYD, JE .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (02) :70-75

[5] EXPRESSION OF ENDOTHELIN-1 IN THE LUNGS OF PATIENTS WITH PULMONARY-HYPERTENSION [J].

GIAID, A ;

YANAGISAWA, M ;

LANGLEBEN, D ;

MICHEL, RP ;

LEVY, R ;

SHENNIB, H ;

KIMURA, S ;

MASAKI, T ;

DUGUID, WP ;

STEWART, DJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (24) :1732-1739

[6] REDUCED EXPRESSION OF ENDOTHELIAL NITRIC-OXIDE SYNTHASE IN THE LUNGS OF PATIENTS WITH PULMONARY-HYPERTENSION [J].

GIAID, A ;

SALEH, D .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (04) :214-221

[7] Long term intravenous prostaglandin (epoprostenol or iloprost) for treatment of severe pulmonary hypertension [J].

Higenbottam, T ;

Butt, AY ;

McMahon, A ;

Westerbeck, R ;

Sharples, L .

HEART, 1998, 80 (02) :151-155

[8]

HIGENBOTTAM W, 1997, 9702 TREND I HLTH SE

[9]

KAPANCI Y, 1990, AM J PATHOL, V136, P881

[10] Minimizing the inhaled dose of NO with breath-by-breath delivery of spikes of concentrated gas [J].

Katayama, Y ;

Higenbottam, TW ;

Cremona, G ;

Akamine, S ;

Demoncheaux, EAG ;

Smith, APL ;

Siddons, TE .

CIRCULATION, 1998, 98 (22) :2429-2432

← 1 2 →